Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneoDx has commercialized multiple in vitro diagnostic products including the first NMPA-approved HPV primary screening DNA methylation triage kit for cervical cancer in China. It also offers multiplex PCR kits capable of detecting up to thirteen pathogen genes simultaneously. The company supports large-scale nucleic acid testing operations and has played a significant role during the COVID pandemic with high-throughput testing labs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai GeneoDx Biotech.